Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Jian ^a,b   Li, Kai ^b   Pang, Qianqian ^c   Yang, Chao ^b   Zhang, Hongyu ^b   Wu, Feng ^b   Cao, Hongqing ^b   Liu, Hongju ^b   Wan, Yumin ^b   Xia, Weibo ^c   Wang, Jinfu ^a   Dai, Zhongquan ^b   Li, Yinghui ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b CHINA ASTRONAUT RESEARCH AND TRAINING CENTER   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MIRN25 MICRORNA, HUMAN;

ANIMAL; BLOOD; DISEASE MODEL; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RHESUS MONKEY; STANDARDS;

ANIMALS; BIOMARKERS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MACACA MULATTA; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPOROSIS; POSTMENOPAUSE; RATS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84994424619     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36347     Document Type: Article

References (49)

1. Kanis, J. A. et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int. 24, 23-57, doi: 10.1007/s00198-012-2074-y (2013).
2. Taipaleenmaki, H., Bjerre Hokland, L., Chen, L., Kauppinen, S. & Kassem, M. Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation. Eur. J. Endocrinol. 166, 359-371, doi: 10.1530/EJE-11-0646 (2012).
3. Tang, P., Xiong, Q., Ge, W. & Zhang, L. The role of microRNAs in osteoclasts and osteoporosis. RNA Biol. 11, 1355-1363, doi: 10.1080/15476286.2014.996462 (2014).
4. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006, doi: 10.1038/cr.2008.282 (2008).
5. Hunter, M. P. et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3, e3694, doi: 10.1371/journal.pone.0003694 (2008).
6. Lawrie, C. H. et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675, doi: 10.1111/j.1365-2141.2008.07077.x (2008).
7. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 105, 10513-10518, doi: 10.1073/pnas.0804549105 (2008).
8. He, Y. et al. Current State of Circulating MicroRNAs as Cancer Biomarkers. Clin. Chem. 61, 1138-1155, doi: 10.1373/clinchem.2015.241190 (2015).
9. Hackl, M., Heilmeier, U., Weilner, S. & Grillari, J. Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases? Mol. Cell Endocrinol. 432, 83-95, doi: 10.1016/j.mce.2015.10.015 (2016).
10. Li, H., Wang, Z., Fu, Q. & Zhang, J. Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients. Biomarkers 19, 553-556, doi: 10.3109/1354750X. 2014.935957 (2014).
11. Cao, Z. et al. MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis. PLoS ONE 9, e97098, doi: 10.1371/journal.pone.0097098 (2014).
12. Seeliger, C. et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J. Bone Miner. Res. 29, 1718-1728, doi: 10.1002/jbmr.2175 (2014).
13. Weilner, S. et al. Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation. Bone 79, 43-51, doi: 10.1016/j.bone.2015.05.027 (2015).
14. Panach, L., Mifsut, D., Tarin, J. J., Cano, A. & Garcia-Perez, M. A. Serum Circulating MicroRNAs as Biomarkers of Osteoporotic Fracture. Calcif. Tissue Int. 97, 495-505, doi: 10.1007/s00223-015-0036-z (2015).
15. Bustin, S. A., Benes, V., Nolan, T. & Pfaffl, M. W. Quantitative real-time RT-PCR-a perspective. J. Mol. Endocrinol. 34, 597-601, doi: 10.1677/jme.1.01755 (2005).
16. Wang, Z. et al. Serum microRNA is a promising biomarker for osteogenesis imperfecta. Intractable Rare Dis. Res. 1, 81-85, doi: 10.5582/irdr.2012.v1.2.81 (2012).
17. Barry, S. E. et al. Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients. J. Cell Mol. Med. 19, 1606-1613, doi: 10.1111/jcmm.12535 (2015).
18. Yang, L. et al. miR-93/Sp7 function loop mediates osteoblast mineralization. J. Bone Miner. Res. 27, 1598-1606, doi: 10.1002/jbmr.1621 (2012).
19. Marabita, F. et al. Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief. Bioinform. 17, 204-212, doi: 10.1093/bib/bbv056 (2015).
20. Song, J. et al. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig. Dis. Sci. 57, 897-904, doi: 10.1007/s10620-011-1981-7 (2012).
21. Mi, Q. S. et al. Identification of mouse serum miRNA endogenous references by global gene expression profiles. PLoS ONE 7, e31278, doi: 10.1371/journal.pone.0031278 (2012).
22. Chen, X. et al. A Combination of Let-7d, Let-7g and Let-7i Serves as a Stable Reference for Normalization of Serum microRNAs. PLoS ONE 8, e79652, doi: 10.1371/journal.pone.0079652 (2013).
23. Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034 (2002).
24. Andersen, C. L., Jensen, J. L. & Orntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245-5250, doi: 10.1158/0008-5472.CAN-04-0496 (2004).
25. De Guire, V. et al. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin. Biochem. 46, 846-860, doi: 10.1016/j.clinbiochem.2013.03.015 (2013).
26. Rittweger, J. et al. Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study. Bone 36, 1019-1029, doi: 10.1016/j.bone.2004.11.014 (2005).
27. LeBlanc, A. et al. Bone mineral and lean tissue loss after long duration space flight. J. Musculoskelet. Neuronal Interact. 1, 157-160 (2000).
28. Das, M. K., Andreassen, R., Haugen, T. B. & Furu, K. Identification of Endogenous Controls for Use in miRNA Quantification in Human Cancer Cell Lines. Cancer genomics & proteomics 13, 63-68 (2016).
29. Johansen, I. & Andreassen, R. Validation of miRNA genes suitable as reference genes in qPCR analyses of miRNA gene expression in Atlantic salmon (Salmo salar). BMC Res. Notes 8, 945, doi: 10.1186/1756-0500-7-945 (2014).
30. Eguchi, T. et al. OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS ONE 8, e58796, doi: 10.1371/journal.pone.0058796 (2013).
31. Balderman, J. A. et al. Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J. Am. Heart Assoc. 1, e003905, doi: 10.1161/JAHA.112.003905 (2012).
32. Zuo, B. et al. microRNA-103a functions as a mechanosensitive microRNA to inhibit bone formation through targeting Runx2. J. Bone Miner. Res. 30, 330-345, doi: 10.1002/jbmr.2352 (2015).
33. Sun, Z. et al. MiR-103 inhibits osteoblast proliferation mainly through suppressing Cav1.2 expression in simulated microgravity. Bone 76, 121-128, doi: 10.1016/j.bone.2015.04.006 (2015).
34. Zhao, R. Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective. Int. J. Med. Sci. 9, 825-832, doi: 10.7150/ijms.5180 (2012).
35. Jilka, R. L. et al. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J. Clin. Invest. 101, 1942-1950, doi: 10.1172/JCI1039 (1998).
36. Taverna, S. et al. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget 6, 21918-21933, doi: 10.18632/oncotarget.4204 (2015).
37. Hudson, M. B. et al. miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosomemediated export. Am. J. Physiol. Cell Physiol. 306, C551-C558, doi: 10.1152/ajpcell.00266.2013 (2014).
38. de Candia, P. et al. Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation. PLoS ONE 8, e75348, doi: 10.1371/journal.pone.0075348 (2013).
39. Lu, C. et al. Wnt-mediated reciprocal regulation between cartilage and bone development during endochondral ossification. Bone 53, 566-574, doi: 10.1016/j.bone.2012.12.016 (2013).
40. Sonda, N. et al. miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity 38, 1236-1249, doi: 10.1016/j.immuni.2013.06.004 (2013).
41. Delic, S. et al. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. Neuro. Oncol. 16, 179-190, doi: 10.1093/neuonc/not164 (2014).
42. Bodine, P. V. et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18, 1222-1237, doi: 10.1210/me.2003-0498 (2004).
43. Hausler, K. D. et al. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J. Bone Miner. Res. 19, 1873-1881, doi: 10.1359/JBMR.040807 (2004).
44. Ishimoto, T. et al. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation. Carcinogenesis 35, 1003-1011, doi: 10.1093/carcin/bgt402 (2014).
45. Li, Y. et al. CD44 deficiency inhibits unloading-induced cortical bone loss through downregulation of osteoclast activity. Sci. Rep. 5, 16124, doi: 10.1038/srep16124 (2015).
46. Xu, W. et al. Association of genetic variants of vit D binding protein (DBP/GC) and of the enzyme catalyzing its 25-hydroxylation (DCYP2R1) and serum vit D in postmenopausal women. Hormones 13, 345-352, doi: 10.14310/horm.2002.1484 (2014).
47. Wronski, T. J. & Morey-Holton, E. R. Skeletal response to simulated weightlessness: a comparison of suspension techniques. Aviat. Space Environ Med. 58, 63-68 (1987).
48. Blondal, T. et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59, S1-S6, doi: 10.1016/j.ymeth.2012.09.015 (2013).
49. McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K. & Algeciras-Schimnich, A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57, 833-840, doi: 10.1373/clinchem.2010.157198 (2011).